|
|
![]() |
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 110, Issue 12 1395-1402, Copyright © 1997 by Company of Biologists
JOURNAL ARTICLES |
L Goretzki and BM Mueller
The Scripps Research Institute, Department of Immunology, La Jolla, CA 92037, USA.
Internalization of the urokinase-type plasminogen activator (uPA) requires two receptors, the uPA receptor (uPAR) and the low density lipoprotein receptor-related protein (LRP)/alpha2-macroglobulin (alpha2M) receptor. Here, we address whether protein kinases are involved in the internalization of uPA by human melanoma cells. Initially, we found that the internalization of uPA was significantly inhibited by the serine/threonine protein kinase inhibitors staurosporine, K-252a and H-89, but not by the tyrosine kinase inhibitors, genistein and lavendustin A. Internalization of uPA was also inhibited by a pseudosubstrate peptide for cAMP-dependent protein kinase (PKA), but not by a pseudosubstrate peptide for protein kinase C. We confirmed a requirement for PKA-activity and implicated a specific isoform by using an antisense oligonucleotide against the regulatory subunit RI alpha of PKA which suppresses PKA-I activity. Exposure of cells to this oligonucleotide led to a specific, dose-dependent decrease in RI alpha protein and to a significant inhibition in the rate of uPA internalization. We further demonstrate that treatment of melanoma cells with either H-89 or PKA RI alpha antisense oligonucleotides also resulted in a decreased internalization of two other ligands of LRP, activated alpha2M and lactoferrin, indicating that PKA activity is associated with LRP. Finally, we demonstrate that PKA activity is also required for the internalization of transferrin, but not for the internalization of the epidermal growth factor or adenovirus 2, suggesting that in melanoma cells, PKA activity is not generally required for clathrin-mediated endocytosis, but is rather associated with specific internalization receptors.
This article has been cited by other articles:
![]() |
S. Thomas, S. Chigurupati, M. Anbalagan, and G. Shah Calcitonin Increases Tumorigenicity of Prostate Cancer Cells: Evidence for the Role of Protein Kinase A and Urokinase-Type Plasminogen Receptor Mol. Endocrinol., August 1, 2006; 20(8): 1894 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Prager, J. M. Breuss, S. Steurer, D. Olcaydu, J. Mihaly, P. M. Brunner, H. Stockinger, and B. R. Binder Vascular Endothelial Growth Factor Receptor-2-Induced Initial Endothelial Cell Migration Depends on the Presence of the Urokinase Receptor Circ. Res., June 25, 2004; 94(12): 1562 - 1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Salazar and A. Gonzalez Novel Mechanism for Regulation of Epidermal Growth Factor Receptor Endocytosis Revealed by Protein Kinase A Inhibition Mol. Biol. Cell, May 1, 2002; 13(5): 1677 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lou, T. McQuistan, R. A. Orlando, and M. G. Farquhar GAIP, GIPC and G{alpha}i3 are Concentrated in Endocytic Compartments of Proximal Tubule Cells: Putative Role in Regulating Megalin's Function J. Am. Soc. Nephrol., April 1, 2002; 13(4): 918 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, P. van Kerkhof, M. P. Marzolo, G. J. Strous, and G. Bu Identification of a Major Cyclic AMP-Dependent Protein Kinase A Phosphorylation Site within the Cytoplasmic Tail of the Low-Density Lipoprotein Receptor-Related Protein: Implication for Receptor-Mediated Endocytosis Mol. Cell. Biol., February 15, 2001; 21(4): 1185 - 1195. [Abstract] [Full Text] |
||||
![]() |
M. E. Martin, J. Hidalgo, J. L. Rosa, P. Crottet, and A. Velasco Effect of Protein Kinase A Activity on the Association of ADP-ribosylation Factor 1 to Golgi Membranes J. Biol. Chem., June 16, 2000; 275(25): 19050 - 19059. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Farias-Eisner, L. Vician, A. Silver, S. Reddy, S. A. Rabbani, and H. R. Herschman The Urokinase Plasminogen Activator Receptor (UPAR) Is Preferentially Induced by Nerve Growth Factor in PC12 Pheochromocytoma Cells and Is Required for NGF-Driven Differentiation J. Neurosci., January 1, 2000; 20(1): 230 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. L. Walker, R. T. Premont, L. S. Barak, M. G. Caron, and M. A. Shetzline Properties of Secretin Receptor Internalization Differ from Those of the beta 2-Adrenergic Receptor J. Biol. Chem., October 29, 1999; 274(44): 31515 - 31523. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Cotlin, M. A. Siddiqui, F. Simpson, and J. F. Collawn Casein Kinase II Activity Is Required for Transferrin Receptor Endocytosis J. Biol. Chem., October 22, 1999; 274(43): 30550 - 30556. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Zerbinatti and C. A. Dyer Apolipoprotein E Peptide Stimulation of Rat Ovarian Theca Cell Androgen Synthesis Is Mediated by Members of the Low Density Lipoprotein Receptor Superfamily Biol Reprod, September 1, 1999; 61(3): 665 - 672. [Abstract] [Full Text] |
||||
![]() |
A. Hamik, H. Setiadi, G. Bu, R. P. McEver, and J. H. Morrissey Down-regulation of Monocyte Tissue Factor Mediated by Tissue Factor Pathway Inhibitor and the Low Density Lipoprotein Receptor-related Protein J. Biol. Chem., February 19, 1999; 274(8): 4962 - 4969. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Martin, J Hidalgo, F. Vega, and A Velasco Trimeric G proteins modulate the dynamic interaction of PKAII with the Golgi complex J. Cell Sci., January 11, 1999; 112(22): 3869 - 3878. [Abstract] [PDF] |
||||